These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34507113)

  • 1. Interweaving epilepsy and neurodegeneration: Vitamin E as a treatment approach.
    Upaganlawar AB; Wankhede NL; Kale MB; Umare MD; Sehgal A; Singh S; Bhatia S; Al-Harrasi A; Najda A; Nurzyńska-Wierdak R; Bungau S; Behl T
    Biomed Pharmacother; 2021 Nov; 143():112146. PubMed ID: 34507113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excitotoxicity, neuroinflammation and oxidant stress as molecular bases of epileptogenesis and epilepsy-derived neurodegeneration: The role of vitamin E.
    Ambrogini P; Torquato P; Bartolini D; Albertini MC; Lattanzi D; Di Palma M; Marinelli R; Betti M; Minelli A; Cuppini R; Galli F
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1098-1112. PubMed ID: 30703511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Antioxidant Anthocyanins-A Hidden Therapeutic Candidate in Metabolic Disorders with Major Focus in Neurodegeneration.
    Ullah R; Khan M; Shah SA; Saeed K; Kim MO
    Nutrients; 2019 May; 11(6):. PubMed ID: 31141884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate drug targets for prevention or modification of epilepsy.
    Varvel NH; Jiang J; Dingledine R
    Annu Rev Pharmacol Toxicol; 2015; 55():229-47. PubMed ID: 25196047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing epileptogenesis: A realistic goal?
    Terrone G; Pauletti A; Pascente R; Vezzani A
    Pharmacol Res; 2016 Aug; 110():96-100. PubMed ID: 27173399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to nerve agents: from status epilepticus to neuroinflammation, brain damage, neurogenesis and epilepsy.
    de Araujo Furtado M; Rossetti F; Chanda S; Yourick D
    Neurotoxicology; 2012 Dec; 33(6):1476-1490. PubMed ID: 23000013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress in epilepsy.
    Geronzi U; Lotti F; Grosso S
    Expert Rev Neurother; 2018 May; 18(5):427-434. PubMed ID: 29651881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and reactive oxygen species as disease modifiers in epilepsy.
    Terrone G; Balosso S; Pauletti A; Ravizza T; Vezzani A
    Neuropharmacology; 2020 May; 167():107742. PubMed ID: 31421074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
    Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
    Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroinflammation impact in epileptogenesis and new treatment strategy.
    Mahfoz AM; Shahzad N
    Behav Pharmacol; 2019 Dec; 30(8):661-675. PubMed ID: 31658099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on the development of antioxidant antiepileptogenic agents.
    Rowles J; Olsen M
    Mini Rev Med Chem; 2012 Sep; 12(10):1015-27. PubMed ID: 22512592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodegeneration and Pathology in Epilepsy: Clinical and Basic Perspectives.
    Farrell JS; Wolff MD; Teskey GC
    Adv Neurobiol; 2017; 15():317-334. PubMed ID: 28674987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of current antiepileptics to prevent neurodegeneration in epilepsy models.
    Pitkänen A
    Epilepsy Res; 2002 Jun; 50(1-2):141-60. PubMed ID: 12151125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanistic approach to explore the neuroprotective potential of zonisamide in seizures.
    Kumar B; Medhi B; Modi M; Saikia B; Attri SV; Patial A
    Inflammopharmacology; 2018 Aug; 26(4):1125-1131. PubMed ID: 29644555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.
    Karnati HK; Panigrahi MK; Gutti RK; Greig NH; Tamargo IA
    J Alzheimers Dis; 2015; 48(3):563-80. PubMed ID: 26402105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epileptogenesis and oncogenesis: An antineoplastic role for antiepileptic drugs in brain tumours?
    Cucchiara F; Pasqualetti F; Giorgi FS; Danesi R; Bocci G
    Pharmacol Res; 2020 Jun; 156():104786. PubMed ID: 32278037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymoquinone and vitamin C attenuates pentylenetetrazole-induced seizures via activation of GABAB1 receptor in adult rats cortex and hippocampus.
    Ullah I; Badshah H; Naseer MI; Lee HY; Kim MO
    Neuromolecular Med; 2015 Mar; 17(1):35-46. PubMed ID: 25429759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective offerings by agmatine.
    Kotagale NR; Taksande BG; Inamdar NN
    Neurotoxicology; 2019 Jul; 73():228-245. PubMed ID: 31063707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.
    Pauletti A; Terrone G; Shekh-Ahmad T; Salamone A; Ravizza T; Rizzi M; Pastore A; Pascente R; Liang LP; Villa BR; Balosso S; Abramov AY; van Vliet EA; Del Giudice E; Aronica E; Antoine DJ; Patel M; Walker MC; Vezzani A
    Brain; 2017 Jul; 140(7):1885-1899. PubMed ID: 28575153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.